Product Details:
- Minoxidil Topical Solution USP 2% is a colorless liquid medication for use only on the top of the scalp to help regrow hair.
- This product is for men who have a general thinning of hair on the top of the scalp (vertex) .
- Minoxidil Topical Solution has been shown to regrow hair in men with the following degrees of thinning hair or hair loss:
- If men have more hair loss than shown above, Minoxidil Topical Solution may not work.
- Minoxidil Topical Solution contains the only ingredient available without a prescription that is medically proven effective to help regrow hair.
- The active ingredient in Minoxidil Topical Solution USP 2% is minoxidil 2% w/v.
- Minoxidil belongs to a class of drugs known as vasodilators.
- This product may contain inactive ingredients, which can cause allergic reactions.
Positive:
- Minoxidil Topical Solution has been shown to regrow hair in men with thinning hair or hair loss.
- Minoxidil Topical Solution contains the only ingredient available without a prescription that is medically proven effective to help regrow hair.
- Minoxidil Topical Solution USP 2% is clinically proven to help regrow hair.
- Minoxidil Topical Solution USP 2% is dermatologist recommended.
Negative:
- If men have more hair loss than shown above, Minoxidil Topical Solution may not work.
- This product may contain inactive ingredients, which can cause allergic reactions.
- Minoxidil Topical Solution is not used for baldness at the front of the scalp or receding hairline in men.
- This medication is not used for sudden/patchy hair loss, unexplained hair loss, or hair loss after giving birth.
- Safety and efficacy of topical minoxidil have not been established in children.
Ingredients or Materials:
- The active ingredient in Minoxidil Topical Solution USP 2% is minoxidil 2% w/v.
- This product may contain inactive ingredients, which can cause allergic reactions.
- Amazon Basic Care Minoxidil Topical Solution USP, 5 Percent, Hair Regrowth Treatment for Men, Extra Strength, Unscented, 2 Fl Oz (Pa...
